CTRI/2019/07/020117已完成4 期
Drug utilization, concurrent, case control study to assess clinical efficacy and safety of Inhaled Beclomethasone in Mild to Moderate asthma.
Glenmark Pharmaceuticals Ltd0 个研究点目标入组 208 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 208
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1. Patients with Bronchial asthma receiving SABAs for at least three days in the last week.
- •2. Mild to Moderate bronchial asthma with post-bronchodilator FEV1 ( >80%) and Reversibility ( >12%)
排除标准
- •1.Patients with < 1 follow up visit to be excluded from this concurrent analyses
- •2.Smoking or Non-smoking Risk factors including exposure to Biomass or Occupational hazard exposure
- •3.Patients on LTRAs &/or antihistamine combinations
- •4.Patients with hospitalization in the last four weeks for Uncontrolled asthma or requiring inhaled SABA of >=6 dosages in a day for the last week.
研究者
相似试验
已完成
4 期
A clinical study to evaluate the effectiveness and safety of a cough clearing formulation in comparison with ambroxol for clearing cough in bronchial asthma.CTRI/2019/04/018694Glenmark Pharmaceuticals Ltd110
已完成
不适用
Drug utilization study in Pimpri Chinchwad (PCMC) area of PuneCTRI/2020/10/028303Amol Gujar
招募中
不适用
To compare Drug Utilization and effects between Ayurveda and Allopathy treatment in patients with Bronchial Asthma.CTRI/2019/10/021481A
尚未招募
Unknown
Evaluation of Medication Usage trend and medication use Behavior among the patients with acneCTRI/2024/07/071536I
尚未招募
4 期
An observational study to evaluate drug utilization pattern and adverse drug reaction profile in radiotherapy and oncology section.CTRI/2016/11/007421Department of Pharmacology Government Medical College Bhavnagar200